Your browser doesn't support javascript.
loading
Virologic and immunologic outcomes of treatment with integrase inhibitors in a real-world setting: The RESPOND cohort consortium.
Neesgaard, Bastian; Mocroft, Amanda; Zangerle, Robert; Wit, Ferdinand; Lampe, Fiona; Günthard, Huldrych F; Necsoi, Coca; Law, Matthew; Mussini, Cristina; Castagna, Antonella; Monforte, Antonella d'Arminio; Pradier, Christian; Chkhartisvilli, Nikoloz; Reyes-Uruena, Juliana; Vehreschild, Jörg Janne; Wasmuth, Jan-Christian; Sönnerborg, Anders; Stephan, Christoph; Greenberg, Lauren; Llibre, Josep M; Volny-Anne, Alain; Peters, Lars; Pelchen-Matthews, Annegret; Vannappagari, Vani; Gallant, Joel; Rieger, Armin; Youle, Mike; Braun, Dominique; De Wit, Stephane; Petoumenos, Kathy; Borghi, Vanni; Spagnuolo, Vincenzo; Tsertsvadze, Tengiz; Lundgren, Jens; Ryom, Lene.
Afiliação
  • Neesgaard B; CHIP, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Mocroft A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, United Kingdom.
  • Zangerle R; Austrian HIV Cohort Study (AHIVCOS), Medizinische Universität Innsbruck, Innsbruck, Austria.
  • Wit F; AIDS Therapy Evaluation in the Netherlands Cohort (ATHENA), Stichting HIV Monitoring (SHM), Amsterdam, Netherlands.
  • Lampe F; Royal Free Hospital, University College London, London, United Kingdom.
  • Günthard HF; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Necsoi C; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Law M; CHU Saint-Pierre, Centre de Recherche en Maladies Infectieuses a.s.b.l., Brussels, Belgium.
  • Mussini C; The Australian HIV Observational Database (AHOD), UNSW, Sydney, Australia.
  • Castagna A; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy.
  • Monforte AD; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy.
  • Pradier C; Italian Cohort Naive Antiretrovirals (ICONA), ASST Santi Paolo e Carlo, Milano, Italy.
  • Chkhartisvilli N; Nice HIV Cohort, Université Côte d'Azur et Centre Hospitalier Universitaire, Nice, France.
  • Reyes-Uruena J; Infectious Diseases, AIDS and Clinical Immunology Research Center, Tbilisi, Georgia.
  • Vehreschild JJ; PISCIS Cohort, Centre d'Estudis Epidemiològics sobre les Infeccions de Transmissió Sexual i Sida de Catalunya (CEEISCAT), CIBERESP, Badalona, Spain.
  • Wasmuth JC; Medical Department 2, Hematology/Oncology, University Hospital of Frankfurt, Frankfurt, Germany.
  • Sönnerborg A; Department I for Internal Medicine, University Hospital of Cologne, Cologne, Germany.
  • Stephan C; University Hospital Bonn, Bonn, Germany.
  • Greenberg L; Swedish InfCare HIV Cohort, Karolinska University Hospital, Stockholm, Sweden.
  • Llibre JM; Infectious Diseases Unit, Medical Dept. no.2, Frankfurt University Hospital, Goethe-University, Frankfurt, Germany.
  • Volny-Anne A; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, United Kingdom.
  • Peters L; Infectious Diseases and Fight AIDS Foundation, Hospital Universitari Germans Trias i Pujol, Barcelona, Spain.
  • Pelchen-Matthews A; European AIDS Treatment Group (EATG), Brussels, Belgium.
  • Vannappagari V; CHIP, Department of Infectious Diseases, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Gallant J; Centre for Clinical Research, Epidemiology, Modelling and Evaluation (CREME), Institute for Global Health, University College London, London, United Kingdom.
  • Rieger A; ViiV Healthcare, Research Triangle, North Carolina, United States of America.
  • Youle M; Gilead Sciences, Foster City, California, United States of America.
  • Braun D; Wiener Medizinische Universität, Vienna, Austria.
  • De Wit S; Royal Free Hospital, University College London, London, United Kingdom.
  • Petoumenos K; Division of Infectious Diseases and Hospital Epidemiology, University Hospital Zurich, Zurich, Switzerland.
  • Borghi V; Institute of Medical Virology, University of Zurich, Zurich, Switzerland.
  • Spagnuolo V; CHU Saint-Pierre, Centre de Recherche en Maladies Infectieuses a.s.b.l., Brussels, Belgium.
  • Tsertsvadze T; The Australian HIV Observational Database (AHOD), UNSW, Sydney, Australia.
  • Lundgren J; Modena HIV Cohort, Università degli Studi di Modena, Modena, Italy.
  • Ryom L; San Raffaele Scientific Institute, Università Vita-Salute San Raffaele, Milano, Italy.
PLoS One ; 15(12): e0243625, 2020.
Article em En | MEDLINE | ID: mdl-33382756
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Inibidores da Protease de HIV / Inibidores da Transcriptase Reversa / Inibidores de Integrase de HIV Idioma: En Ano de publicação: 2020 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Infecções por HIV / Inibidores da Protease de HIV / Inibidores da Transcriptase Reversa / Inibidores de Integrase de HIV Idioma: En Ano de publicação: 2020 Tipo de documento: Article